Ordinary Rebalance | Solactive Global Healthcare 20 Index | Effective Date 22nd January 2024
In the ordinary rebalance, the following composition will be implemented effective open 22.01.2024:
| ABBOTT LABORATORIES |
| ABBVIE INC |
| AMGEN INC |
| ASTRAZENECA PLC |
| BRISTOL-MYERS SQUIBB CO |
| DANAHER CORP |
| ELI LILLY & CO |
| GILEAD SCIENCES INC |
| INTUITIVE SURGICAL INC |
| JOHNSON & JOHNSON |
| MEDTRONIC PLC |
| MERCK & CO. INC. |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| PFIZER INC |
| ROCHE HOLDING AG |
| SANOFI SA |
| STRYKER CORP |
| THERMO FISHER SCIENTIFIC INC |
| VERTEX PHARMACEUTICALS INC |